European Pharmaceutical Law Review
SJR0.109
DE
DEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.109 | Q4 | 2.7% | |
| 2024 | — | — | 0.151 | Q3 | 20.2% | |
| 2023 | — | — | 0.162 | Q3 | 27.8% | |
| 2022 | — | — | 0.116 | Q4 | 19.7% | |
| 2021 | — | — | — | 6.9% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2511-7181
ISSN
2511-7157
country
DEcoverage
2019-2022